Your Notifications
All done, no notifications
Dr. Prof. Giampaolo Bianchini

Dr. Prof. Giampaolo Bianchini

Medical Oncologist ·
, milan, Italy

23 Years of experience ·
Languages Spoken: English, Italian

Book a video consultation with Prof. Giampaolo Bianchini for Medical Oncologist, from USD 503. Receive a signed report within 24 hours or a full refund if unavailable.
USD 503per video consult
Book & Pay – USD 503Chat on WhatsApp Free 15-min Screening

Specialises in:

Early-stage breast cancerLocally advanced breast cancerMetastatic breast cancerEstrogen receptor-positive breast cancerEstrogen receptor-negative breast cancer

About Dr. Prof. Giampaolo Bianchini

  • Prof. Giampaolo Bianchini is a specialist in medical oncology, with a particular focus on breast cancer.
  • He is the Head of Breast Oncology in the Department of Medical Oncology at IRCCS Ospedale San Raffaele, Italy.
  • He is also an Associate Professor at Vita-Salute San Raffaele University.
  • He has nearly 25 years of clinical experience managing patients with early-stage and metastatic breast cancer, according to the supplied biography.
  • His clinical expertise includes the assessment and treatment of breast cancer at different stages of the disease.
  • He has a strong research interest in developing new cancer therapies, including immunotherapy approaches for breast cancer.
  • He is responsible for the translational clinical research and immunotherapy group within the Department of Medical Oncology.
  • His research focuses on understanding how breast cancers respond or become resistant to treatment, identifying new therapeutic strategies, and investigating biomarkers that may help personalize treatment.
  • He has undertaken research training at leading American institutions, including the National Cancer Institute in Bethesda, MD Anderson Cancer Center in Houston, and Yale Cancer Center in New Haven.
  • He has authored numerous scientific publications in international journals, including Nature, The Lancet, Annals of Oncology, The Lancet Oncology, Journal of Clinical Oncology, and Nature Medicine.

Conditions treated by Prof. Giampaolo BIANCHINI

  • Early-stage breast cancer
  • Locally advanced breast cancer
  • Metastatic breast cancer
  • Estrogen receptor-positive breast cancer
  • Estrogen receptor-negative breast cancer
  • HER2-positive breast cancer, where relevant to the patient's diagnosis
  • Triple-negative breast cancer

Area of Interest

  • Breast oncology
  • Early-stage and metastatic breast cancer
  • Medical management of breast cancer
  • Systemic anticancer therapies
  • Immunotherapy for breast cancer
  • Development of new breast cancer treatments
  • Translational cancer research

Qualification

  • Degree in Medicine and Surgery - University of Milano-Bicocca, Italy, 2000
  • Specialization in Medical Oncology - University of Milan, Italy, 2004

Work Experiences

  • Head of Breast Oncology, Department of Medical Oncology - IRCCS Ospedale San Raffaele, Milan, Italy
  • Associate Professor - Vita-Salute San Raffaele University, Italy
  • Visiting Scientist - National Cancer Institute, Bethesda, USA
  • Visiting Scientist - MD Anderson Cancer Center, Houston, USA
  • Visiting Scientist - Yale Cancer Center, New Haven, USA
  • Head/Lead of Translational Clinical Research and Immunotherapy Group - Department of Medical Oncology, according to the supplied biography

Ready to Speak with Prof. Giampaolo Bianchini?

Book a secure video consultation for expert Cancer Specialist care.

Book Consultation

What to Expect in Your Consultation

Upload Your Medical Reports

Upload MRI/CT scans, laboratory reports, prescriptions, and previous medical records. Supported formats: PDF, JPEG, and DICOM.

30-Min Video Consultation

Consult the Doctor in your preferred language. A family member or caregiver is welcome to join.

Medical Opinion Within 24 Hours

Receive a signed medical opinion with diagnosis, treatment recommendations, and next steps in a downloadable PDF.

Care Coordination (Optional)

If needed, our team can assist with a second opinion, hospital appointments, or medical travel arrangements.

Procedures Performed

Breast Cancer Treatment
Chemotherapy
Immunotherapy

Frequently Asked Questions

Prof. Giampaolo BIANCHINI is available to teleconsult on the MediGence platform.

The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s questions and the doctor's medical recommendations.

We have Medical specialists and board-certified doctors on our panel. The consultation will be organised within 24 to 48 hours, or based on the availability of the doctor and the patient.

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

The option to share your medical records is available between steps in the form provided on the website.

Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, with assistance from our case managers.

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Medical Oncologist

A medical oncologist specializes in treating cancer using medicines and other systemic therapies. Depending on the type and stage of cancer, treatment may include chemotherapy,

Personalized treatment means selecting therapies based on the cancer's characteristics and the patient's individual circumstances. Factors may include tumour subtype, hormone receptor and HER2 status, disease stage, previous treatment, relevant biomarkers, genetic findings, and the patient's preferences.

Biomarkers are measurable biological features that can provide information about a cancer's behaviour or its likelihood of responding to particular treatments. Examples include estrogen and progesterone receptors, HER2 status, and selected molecular or genomic markers. Not every patient needs every available biomarker test.

Cancer cells can change over time, allowing some cells to survive treatment and continue growing. Resistance may develop through genetic changes, alterations in cell signalling, or other biological mechanisms. Further testing and a review of the patient's treatment history may help the oncology team consider alternative options.

Translational research connects laboratory discoveries with clinical care. In breast cancer, it can help researchers understand why treatments work or fail, identify potential biomarkers, and develop new therapies that may improve future patient outcomes.

Clinical trials investigate new treatments or new ways of using existing therapies. Some trials may be suitable for patients with early-stage disease, while others focus on advanced or metastatic cancer. Eligibility depends on the study's criteria, the patient's medical history, and the treating team's assessment.

No. Chemotherapy is not necessary for every patient. The decision depends on the cancer's stage, subtype, risk of recurrence, relevant test results, and the expected benefits and risks of treatment. Other options may include surgery, radiotherapy, hormone therapy, targeted therapy, or immunotherapy, depending on the case.

Explore Telemedicine Specialists

Please Enquire

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Not Sure About Your Treatment Plan? Get a Second Opinion

Get your medical reports reviewed by experienced doctors to help you make a confident treatment decision, all online within 48 hours.